Progyny, Inc. Cash and Restricted Cash
Progyny, Inc. (PGNY) had Cash and Restricted Cash of $154.60 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $154.60M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $133.57M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $114.19M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $139.98M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $154.60M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $133.57M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $114.19M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $139.98M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $137.54M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $114.24M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $162.31M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $91.48M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $94.96M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $114.96M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $97.30M 10-K · filed 2026-02-27 |
| 2023-09-30 | $158.07M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $170.57M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $155.32M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $120.08M 10-K · filed 2026-02-27 |
| 2022-09-30 | $72.52M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $54.73M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $38.82M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $91.41M 10-K · filed 2025-03-03 |
| 2021-09-30 | $92.22M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $48.75M 10-Q · filed 2022-08-05 |
| 2020-12-31 | $70.31M 10-K · filed 2024-02-29 |
| 2019-12-31 | $80.38M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |